| Pooja Suresh, | |
|
1200 Old York Rd, Abington, PA 19001-3720 | |
| (215) 481-2400 | |
| (215) 481-7438 |
| Full Name | Pooja Suresh |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 13 Years |
| Location | 1200 Old York Rd, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821389248 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Abington Memorial Hospital | Abington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
News Archive
A signal came Thursday when the Internal Revenue Service posted drafts of forms that employers will have to fill out to comply with the requirement that they provide workers with health insurance.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).
To further accelerate COVID-19 research on a global scale, investigators from the University of Colorado Anschutz Medical Campus have created a multidimensional dataset, known as the COVIDome dataset, derived from hospitalized COVID-19 patients versus negative controls.
Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.
› Verified 8 days ago
| Entity Name | Amh Medical Staff Service Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356384457 PECOS PAC ID: 9830003813 Enrollment ID: O20031114000011 |
News Archive
A signal came Thursday when the Internal Revenue Service posted drafts of forms that employers will have to fill out to comply with the requirement that they provide workers with health insurance.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).
To further accelerate COVID-19 research on a global scale, investigators from the University of Colorado Anschutz Medical Campus have created a multidimensional dataset, known as the COVIDome dataset, derived from hospitalized COVID-19 patients versus negative controls.
Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.
› Verified 8 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730122789 PECOS PAC ID: 3274437736 Enrollment ID: O20040325000316 |
News Archive
A signal came Thursday when the Internal Revenue Service posted drafts of forms that employers will have to fill out to comply with the requirement that they provide workers with health insurance.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).
To further accelerate COVID-19 research on a global scale, investigators from the University of Colorado Anschutz Medical Campus have created a multidimensional dataset, known as the COVIDome dataset, derived from hospitalized COVID-19 patients versus negative controls.
Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pooja Suresh, 2500 Maryland Rd Ste 400, Willow Grove, PA 19090-1225 Ph: (215) 481-3064 | Pooja Suresh, 1200 Old York Rd, Abington, PA 19001-3720 Ph: (215) 481-2400 |
News Archive
A signal came Thursday when the Internal Revenue Service posted drafts of forms that employers will have to fill out to comply with the requirement that they provide workers with health insurance.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).
To further accelerate COVID-19 research on a global scale, investigators from the University of Colorado Anschutz Medical Campus have created a multidimensional dataset, known as the COVIDome dataset, derived from hospitalized COVID-19 patients versus negative controls.
Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.
› Verified 8 days ago
Dr. Shaili Nepal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2191 Fax: 215-481-3411 | |
Muhammad Arslan Asghar Cheema, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2222 Fax: 215-481-4361 | |
Margaret Mack, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1200 Old York Rd, Abington, PA 19001 Phone: 215-481-2000 | |
Joseph Guererri Crocetti Jr., DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Dr. Joseph Mcallister, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Ste 113, Abington, PA 19001 Phone: 215-517-1180 | |
William L. Ward, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Suite 121, Abington, PA 19001 Phone: 215-517-1200 Fax: 215-517-1219 | |
Rebecca Jane Fallis, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd Ste 220, Abington, PA 19001 Phone: 215-481-6350 Fax: 215-481-4237 |